Return to Listing

7 result(s) for Other

PI Name Protocol # Title
Gordon Mills STUDY00016113 Molecular Mechanisms of Tumor Evolution and Resistance to Therapy
Rajan Kulkarni STUDY00017648 VAPORHCS/OHSU J: Isolation and analysis of circulating tumor cells (CTCs) and nucleic acids from patient blood specimens
Erika Cottrell STUDY00021282 Understanding the Experience of Adolescent and Young Adult Cancer (AYA Cancer Study)
Richard Maziarz STUDY00021423 A Phase 1/2 Study of RTX-240 Monotherapy
Christopher Ryan STUDY00021677 [NCI CIRB] NCICOVID - NCI COVID-19 in Cancer Patients Study (N-CCaPS): A Longitudinal Natural History Study
Christopher Ryan STUDY00021824 A Phase 4, Multicenter Study to Evaluate Discontinuation and Re-Treatment in Subjects with Tenosynovial Giant Cell Tumor (TGCT) Previously Treated with Pexidartinib
Rebecca Silbermann STUDY00022542 [NCI CIRB] EAA181: Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended For Early Autologous Transplantation

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080